IPP Bureau
Thermo Fisher Scientific confirms its TaqParth Covid-19 kit can detect Omicron
By IPP Bureau - November 29, 2021
The Omicron variant, which was designated a variant of concern by the World Health Organization (WHO), has more than 30 mutations in the spike protein alone
ZenOnco.io raises US $ 1.4 mn in seed funding
By IPP Bureau - November 29, 2021
The funds will be used to scale up existing operations and launch new products
Masimo Rad-G helps identify paediatric pneumonia in India
By IPP Bureau - November 29, 2021
Rad-G is a rugged, portable, handheld Masimo SET Measure-through Motion and Low Perfusion pulse oximeter and noninvasive respiration rate monitor
Bharat Biotech commences export of Covaxin
By IPP Bureau - November 29, 2021
It’s a two-dose vaccine administered 28 days apart
Govt increased expenditure on health during 2013 - 18 : Report
By IPP Bureau - November 29, 2021
Share of government health expenditure in total health expenditure increases to 40.8% (2017-18) from 28.6% (2013-14)
Organ transplants see a rise in India
By IPP Bureau - November 28, 2021
Maharashtra won the award for the highest number of deceased donors transplantations
Fujifilm launches awareness campaign on detecting TB
By IPP Bureau - November 28, 2021
The campaign aims to increase awareness about Tuberculosis as a curable disease and promote early diagnosis.
Merck and Ridgeback Biotherapeutics Covid-19 pill less effective
By IPP Bureau - November 28, 2021
Merck has shared these additional analyses with the FDA and they will be presented to the FDA’s Antimicrobial Drugs Advisory Committee on Nov. 30th
Fifty-five manufacturers selected for Pharma PLI sector
By IPP Bureau - November 27, 2021
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
Network18 Group and Novartis India launch ‘Netra Suraksha’ to raise awareness around diabetic eye diseases
By IPP Bureau - November 27, 2021
The aim is to create an awareness programme that will drive diabetic patients to get their eyes tested regularly
Pharma firms switch to advanced pharma manufacturing
By IPP Bureau - November 27, 2021
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
Nykode Therapeutics enters multi-target license and collaboration agreement with Regeneron
By IPP Bureau - November 26, 2021
The multi-target agreement covers five programmes focused on off-the-shelf vaccines for cancer and infectious disease
Baidu and Sanofi to collaborate for next-gen mRNA therapy and vaccines
By IPP Bureau - November 26, 2021
This agreement marks a milestone for Baidu to use its strengths in computational biology to optimize mRNA vaccine and therapy designs
Aadi Bioscience secures U.S FDA approval of its first product Fyarro
By IPP Bureau - November 26, 2021
Fyarro is the first and only approved therapy for adults for the treatment of malignant PEComa in adults
Sanofi invests US $ 180 mn in Owkin’s AI for oncology pipeline
By IPP Bureau - November 26, 2021
Owkin builds best-in-class predictive biomedical AI models and robust data sets
